Axovant Reports Positive Interim Results From First Cohort Of SUNRISE-PD Phase 2 Trial Of AXO-Lenti-PD Gene Therapy In Parkinson’s Disease March 11, 2019 - NASDAQ Companies 0 » View More News for March 11, 2019
